Novo Nordisk (NVO)
(Delayed Data from NYSE)
$134.42 USD
+0.85 (0.64%)
Updated Aug 14, 2024 04:00 PM ET
After-Market: $134.40 -0.02 (-0.01%) 5:20 PM ET
3-Hold of 5 3
D Value B Growth F Momentum D VGM
Brokerage Reports
Novo Nordisk A/S [NVO]
Reports for Purchase
Showing records 41 - 60 ( 196 total )
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
To Bleed or Not To Bleed, That Is the $40B Question for Novel Hem-B Nonfactor Replacement Treatments
Provider: H.C. Wainwright & Co., Inc.
Analyst: TRUCCHIO P
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department